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Abstract
Background: Human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) is a DNA polymerase that converts viral
RNA genomes into proviral DNAs. How HIV-1 RT regulates nucleotide selectivity is a central issue for genetics and the
nucleoside analog RT inhibitor (NRTI) resistance of HIV-1.
Methodology/Principal Findings: Here we show that an ATP molecule at physiological concentrations acts as an allosteric
regulator of HIV-1 RT to decrease the Km value of the substrate, decrease the kcat value, and increase the Ki value of NRTIs for
RT. Computer-assisted structural analyses and mutagenesis studies suggested the positions of the ATP molecule and NRTI-
resistance mutations during a catalytic reaction, which immediately predict possible influences on nucleotide insertion into
the catalytic site, the DNA polymerization, and the excision reaction.
Conclusions/Significance: These data imply that the ATP molecule and NRTI mutations can modulate nucleotide selectivity
by altering the fidelity of the geometric selection of nucleotides and the probability of an excision reaction.
Citation: Yokoyama M, Mori H, Sato H (2010) Allosteric Regulation of HIV-1 Reverse Transcriptase by ATP for Nucleotide Selection. PLoS ONE 5(1): e8867.
doi:10.1371/journal.pone.0008867
Editor: Jean-Pierre Vartanian, Institut Pasteur, France
Received October 28, 2009; Accepted January 5, 2010; Published January 25, 2010
Copyright:  2010 Yokoyama et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by a grant from the Ministry of Health, Labor and Welfare, Japan. The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: yokoyama@nih.go.jp
Introduction
Humanimmunodeficiencyvirustype1reversetranscriptase(HIV-
1 RT) is an RNA-dependent DNA polymerase that converts single-
stranded viral RNA genomes into double-stranded proviral DNAs
after HIV-1 entry into the cells. Active HIV-1 RT is composed of two
related chains, termed p51 and p66 [1]. The p66 chain has a catalytic
site for DNA polymerization: the fingers, palm, and thumb
subdomains form a cavity for the binding of the template, primer,
two divalent cations, and dNTPs for DNA synthesis [1], as seen in
other DNA polymerases. Although HIV-1 RT exhibits no
exonucleolytic proofreading activity, it still retains a relatively high
level of fidelity of DNA synthesis, i.e., about 2.5–6610
24 base
substitutions per site [2,3]. Increasing evidence suggests that the high
fidelity of DNA synthesis achieved by DNA polymerases—i.e., the
discrimination of the correct and incorrect nucleotides for polymer-
ization—is primarily due to the geometric selection of nucleotides
during nucleotide insertion into the catalytic site [4,5,6].
An ATP molecule is a multifunctional nucleotide that exists at a
concentration of ,3.2 mM in the cells [7]. Many studies have
suggested that the ATP molecule is a cellular factor involved in the
drug resistance of HIV-1. Nucleoside analog RT inhibitors
(NRTIs) act as chain terminators blocking DNA synthesis, since
they lack the 39-OH group required for the phosphodiester bond
formation, whereas NRTI-resistant RT catalyzes dinucleoside
polyphosphate synthesis in the presence of millimolar concentra-
tions of NTP [8]. Thus, the ATP molecule at physiological
concentrations in vitro serves as an effective pyrophosphate donor
to the excision reaction of the RT to remove the chain terminating
NRTIs [8,9,10]. A previous crystal structure study identified a
binding site of ATP in the catalytic cavity of p66 when the RT was
free from the template and primer [11]. Although ATP-mediated
excision provides a plausible mechanism for the NRTI resistance
of HIV-1, some NRTI-resistance mutations are located distantly
from the excision site. Therefore, their roles in NRTI resistance
are not fully understood [12].
Enzyme activity is often modulated by an allosteric effector, a
small natural compound that binds to the enzyme at a site distinct
from the substrate-binding site. In this study, we show by kinetic,
structural, and mutagenesis studies that the ATP molecule can act
as an allosteric effector of HIV-1 RT to modulate nucleotide
selectivity and DNA polymerization. We also show probable three-
dimensional (3-D) positions of the bound ATP molecule and
NRTI-resistance mutations during a catalytic cycle. The obtained
data suggest that the ATP molecule and NRTI mutations can
cooperatively modulate physicochemical properties of the p66
catalytic cavity to alter the fidelity of the geometric selection of
nucleotides and the probability of an excision reaction.
Results
Effects of ATP on HIV-1 RT Reaction Kinetics
First, we analyzed the effects of ATP on HIV-1 RT reaction
kinetics. We began by collecting basic information on the steady-
state kinetics of DNA polymerization in the absence of the ATP
molecule. We used two HIV-1 RTs for the present study: the
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(ERT-mt6) [13]. The ERT-mt6 RT has an 11-amino-acid
insertion in the b3-b4 loops of the p66 fingers subdomain and
four substitutions–M41L, T69I, L210W, and T215Y–in the
polypeptide backbone of 93JP-NH1 [13]. These mutations confer
higher levels of resistance of the 93JP-NH1 virus against AZT,
d4T, b-L-29,39-dideoxy-3-thiacytidine, 29,39-dideoxyinosine, and
29,39-dideoxycytidine than other mutants in the polypeptide
backbone of 93JP-NH1 [13]. Therefore, we used ERT-mt6 RT,
which clearly showed that NRTI-resistance mutations enhance the
effect of ATP on enzyme kinetics in NRTI-sensitive RT.
The initial velocities of dTTP incorporation into poly
(rA)?p(dT)12-18 were measured using purified p51/p66 RT
heterodimers of the 93JP-NH1 and ERT-mt6 RTs (Figure S1A).
In both RTs, the dTTP incorporation followed Michaelis-Menten
kinetics (Figure S1B). The Km values for the 93JP-NH1 and ERT-
mt6 RTs were 4.060.1 and 13.860.5 mM, respectively, suggesting
that the dTTP has a higher Km value for ERT-mt6 RT. The kcat
values for 93JP-NH1 and ERT-mt6 RTs were 1.0460.01 and
0.4960.01s
21, respectively, suggesting that ERT-mt6 RT has a
nucleotide addition reaction with a slower turnover rate.
We then used the two RTs to examine whether or not the ATP
molecule influences the DNA polymerization kinetics by measur-
ing the initial velocity of dTTP incorporation into poly
(rA)?p(dT)12-18 in the presence of 0, 1, 2, 3, and 4 mM of ATP.
The velocity is decreased in both RTs in association with an
increase in ATP concentration, indicating that the ATP molecule
inhibits the overall catalytic reaction by HIV-1 RT (Figure 1A).
Lineweaver-Burk double-reciprocal plots showed that, in both
RTs, the straight lines at the different ATP concentrations have
different x- and y-intercepts, and that the line slope increases with
increasing ATP concentration (Figure 1B). The data suggest that
the ATP-mediated inhibition of dTTP incorporation is a mixed
noncompetitive inhibition.
We further examined whether or not the ATP molecule can
influence the Km of substrate and kcat values in the enzyme reaction.
The substrate-velocity data in Figure 1A were fit to Equations 1
and 2 (see Materials and Methods), and the average Km and kcat
values in the presence of 0, 1, 2, 3, and 4 mM of ATP were
obtained with six independent experiments. Notably, both Km and
kcat values for the 93JP-NH1 and ERT-mt6 RTs monotonically
decreased with increasing ATP concentration (Figure 1C).
We also examined the Ki values of ATP to the two RTs. On the
basis of information on the RT catalytic cycle [14], we assumed
two structures of RT for ATP binding: the RT-template-primer
complex (RT complex 1) and the RT-template-primer-dTTP
complex (RT complex 2). Using Equations 3 and 4 (see Materials
and Methods), we calculated Ki
ATP and Ki9
ATP values of ATP to
the RT complexes 1 and 2, respectively. The Ki
ATP values were
2.961.3 and 2.861.3 mM for the 93JP-NH1 and ERT-mt6 RTs,
respectively, suggesting that the ATP molecule binds with the
equivalent Ki
ATP value to complex 1 of the two RTs. The Ki9
ATP
values were 1.260.5 and 1.160.4 mM for the 93JP-NH1 and
ERT-mt6 RTs, respectively, suggesting that the ATP molecule
also binds with the equivalent Ki9
ATP value to complex 2 of these
RTs. These results are consistent with the finding that AZT
resistance mutations cause no difference in ATP binding [15,16].
Finally, the Ki
ATP value was larger than the Ki9
ATP value in both
RTs, suggesting that ATP binds with higher affinity to the dTTP-
bound RT than to the substrate-free RT.
ATP’s Effects on NRTI Action
Next, we examined whether or not the ATP molecule influences
the action of NRTI on the two RTs. In the absence of the ATP
molecule, nanomole orders of AZTTP effectively inhibited dTTP
incorporation by both RTs (Figure 2A, top), suggesting that, in the
absence of the ATP molecule, the level of inhibition of DNA
polymerization by AZTTP is equivalent between the two RTs. In
the presence of 1 mM ATP, the inhibition was more moderate
with the ERT-mt6 RT than with the 93JP-NH1 RT, and the
difference in the inhibition curve became much greater in the
presence of 5 mM ATP (Figure 2A, middle and bottom). These
data suggest that the ATP molecule and NRTI mutations
cooperatively reduce the NRTI sensitivity of HIV-1 RT in vitro.
We next examined whether or not the above ATP effects on
NRTI resistance were specific to the ATP molecule by measuring
the IC50 of AZTTP in the presence of 5 mM UTP, CTP, GTP,
NaPO4, dATP, ADP, cAMP, and AMP-PNP (Figure 2B). While
many of the compounds tested increased the IC50 of AZTTP, the
magnitude of the fold increase was consistently greater with ERT-
mt6 RT than 93JP-NH1 RT. The ATP molecule was most
effective at increasing the IC50, yielding an approximately 350-fold
increase with the ERT-mt6 RT. The ATP, dATP, and GTP
molecules, which have a purine ring, had greater effects on the
IC50 increase than the UTP and CTP molecules, which have a
pyrimidine ring. NaPO4 and cAMP had little effect on the IC50 in
either RT. Notably, AMP-PNP, a non-hydrolyzed analogue of the
ATP molecule, also increased the IC50 of AZTTP by approxi-
mately 150-fold with the ERT-mt6 RT. These data suggest that
nucleotides similar in size to the ATP molecule can assist in the
development of NRTI resistance.
We further examined whether or not the ATP molecule
influences the Ki values of AZTTP and d4TTP to the two RTs in
the enzyme reaction. Based on the kinetics data for ATP in
Figure 1, the kinetics data for AZTTP in Figure S2, the reported
kinetics data for AZTTP inhibition [17,18], and a crystal structure
study of the ATP-RT complex [11], a simplified kinetics model in
which ATP functions as a mixed noncompetitive inhibitor and
nucleoside analogs function as competitive inhibitors was hypoth-
esized (Figure 2C). We measured the initial velocities of dTTP
incorporation by HIV-1 RTs at various ATP concentrations and
various AZTTP or d4TTP concentrations, and calculated the Ki
values of these compounds for the 93JP-NH1 and ERT-mt6 RTs
using Equations 5 and 6 (see Materials and Methods). Notably, the
ATP molecule induced increases in the Ki
NRTI value in a dose-
dependent manner. The magnitudes of the increases were much
greater with ERT-mt6 RT, reaching about 30-fold for the Ki
AZTTP
value and 8.5-fold for the Ki
d4TTP value at 3 mM of ATP
compared to those without the ATP molecule (Figure 2D). The
magnitude of changes in Ki
NRTI values was much smaller with
93JP-NH1 RT, which yielded about 6.8- and 0.6-fold increases in
Ki
AZTTP and Ki
d4TTP values, respectively, at 3 mM of ATP
compared to those without the ATP molecule. These data suggest
that physiological concentrations of ATP [7] potently increase the
Ki value of NRTI when RT has NRTI-resistance mutations.
Structural Study on ATP Action
A previous study identified a binding site of the ATP molecule
in the p66 when the RT was free from the template and primer
[11]. To address the binding site of the ATP molecule in RT
during DNA synthesis, we conducted a computer-assisted
structural analysis. Using the homology modeling method [19],
we first constructed 3-D models of 93JP-NH1 and ERT-mt6 RTs
at various catalytic stages defined by biochemical and crystallo-
graphic data [14,20,21] (Figure 3). In the DNA polymerization
processes, each single nucleotide addition cycle was divided into
four steps, termed the post-translocation, fingers-open ternary,
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(Figure 3).
The 3-D models were used to search for a possible binding site
for nucleotides by docking simulations [22]. A previous study
suggested that incoming dNTP and NRTIs bind along the p66
fingers subdomain of the fingers-open ternary RT complex at the
post-translocation stage [23] (Figures 3A and 3B), as is generally
seen in other polymerases [24,25,26,27,28]. The binding position
was in agreement with the biochemical mode of NRTI inhibition,
competitive inhibition, as shown by our kinetic study of AZTTP
(Figure S2) and previous studies [17,18]. This position was also
consistent with the position needed to initiate the base pair
formation at the enzyme active center after rotation (,20u) of the
b3-b4 loops to form a fingers-closed ternary complex [5]
(Figures 3B and 3C).
The 3-D models of pre- and post-translocation complexes
corresponding to E and ES in the kinetic model (Figure 2C) were
used to search for a possible binding site for the ATP molecule by
docking simulations [22]. The simulations suggested that the ATP
molecule could bind to the 93JP-NH1 and ERT-mt6 RTs at the
pre-translocation (Figure 3D) and the post-translocation
(Figure 3A) stages. The ATP molecule was predicted to bind
Figure 1. Effects of ATP on HIV-1 RT reaction kinetics. A. The substrate-velocity curves of purified HIV-1 RTs in the presence of ATP. RNA-
dependent DNA polymerase activity [13] of the purified RTs was measured using various concentrations of [a-
32P]dTTP and poly (rA)?p(dT)12-18 in the
presence of ATP. Representative results with 93JP-NH1 RT (left) and ERT-mt6 RT (right) are shown. B. Lineweaver-Burk double-reciprocal plots for
ATP-dependent inhibition of dTTP incorporation. Reciprocal values of the initial velocities and substrate concentrations in Figure 1A are plotted. C.
Effects of ATP on Km (left) and kcat (right) values in RT reaction. The Km and kcat values were estimated by fitting of the initial velocity of dTTP
incorporation to Equations 3 and 4 as described in Materials and Methods. The mean values with variances of the six independent experiments are
shown.
doi:10.1371/journal.pone.0008867.g001
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PLoS ONE | www.plosone.org 3 January 2010 | Volume 5 | Issue 1 | e8867Figure 2. Effects of ATP on NRTI action. A. Effects of ATP on AZTTP-dependent inhibition of RT activities. The dTMP incorporation into poly
(rA)?p(dT)12-18 was measured using [a-
32P]dTTP and purified p51/p66 heterodimers in the presence of the indicated concentrations of ATP and AZTTP.
Ratios of the dTTP incorporation at given concentrations of AZTTP to that in the absence of AZTTP are shown. B. Effects of nucleotides and related
compounds on IC50s of AZTTP. IC50s of AZTTP were determined in the presence of 5 mM of the indicated compounds, and the fold increases in IC50
compared to AZTTP without the compounds are shown. C. A simplified kinetics model of DNA polymerization in the presence of ATP and NRTI. The
model was generated on the basis of the kinetics data in Figure 1 and Figure S2, previously reported kinetics data [17,18], and a crystal structure
study of the ATP-RT complex [11]. D. Effects of ATP on the Ki values of AZTTP and d4TTP. The Ki
AZTTP and Ki
d4TTP values were estimated by fitting the
initial velocity of dTTP incorporation to Equation 5 as described in Materials and Methods. The mean values with variances are shown for two
independent experiments performed with duplicate samples.
doi:10.1371/journal.pone.0008867.g002
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D110, D113, F116, D185, and K219 residues at the p66 fingers
subdomain of both RTs (Figure 4). The ATP-binding position was
stabilized through electrostatic and hydrophobic interactions
between the ATP molecule and the side chains of surrounding
amino acids. The ATP position was similar to the ATP position in
the crystal structure of the template-primer-free RT [11] and was
indistinguishable between the pre- and post-translocation stages
(Figure S3), suggesting that a specific ATP-binding site is preserved
in the free-RT and RT-template-primer tertiary complex. The
ATP-binding position was distinct from that of dNTP at initial
binding [23] and after fingers-domain rotation [1] in the fingers-
open and -closed configurations of RT, respectively (Figures 3 and
4), consistent with our kinetic data for allosteric regulation
(Figures 1 and 2).
The bound ATP molecule was located near the YMDD motif,
motif A, and the 39-end of the primer, suggesting that the ATP
binding can modulate polymerization and support the excision
Figure 3. Structural models of the HIV-1 RT p66 subunit in a DNA polymerization cycle. The 3-D models of the 93JP-NH1 p66-template-
primer ternary complex of the fingers-open configuration at post-translocation (A), fingers-open configuration at the stage of dTTP binding (B),
fingers-closed configuration after fingers-rotation (C), and fingers-open configuration at pre-translocation stage (D). The models were constructed by
homology modeling and docking simulation techniques using two crystal structures [1,14] of the HIV-1 RTs as modeling templates (see Materials and
Methods). Catalytic clefts composed of fingers, palm, and thumb subdomains are shown. dTTP, magenta sticks; p66 main chain, grey ribbon; Mg
2+
ion, gray spheres; template-primer, grey sticks; b3-b4 loop of the fingers subdomain, blue ribbon.
doi:10.1371/journal.pone.0008867.g003
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between the catalytic site and the b3-b4 loops, suggesting that the
ATP binding can modulate the initial binding and translocation of
dNTP and NRTIs into the catalytic site (Figures 3 and 4). Taken
together, these structural data are well consistent with our kinetic
data, biochemical data for excision [8,9,10], and crystal structure
data for ATP binding [11].
NRTI-resistance mutations of the ERT-mt6 p66 (Figure 4,
orange residues) were located relatively far away from the bound
ATP molecule and catalytic center in p66. Thus, it is less likely
that these mutations directly influence the ATP-mediated excision.
Instead, the M41L, T69I, L210W, and T215Y substitutions
augmented the hydrophobicity of the catalytic cavity of p66, which
could enhance p66’s ability to exclude water from the catalytic site
cleft for a higher fidelity of nucleotide selection [6,29]. This
possibility is consistent with our kinetic data. The fingers-domain
insertion induced changes in the shape of the b3-b4 loops that
could alter the position of the initial binding site of dNTP and
NRTI relative to the catalytic site.
Site-Directed Mutagenesis Study
We further examined how substitutions of amino acids around
the predicted ATP-binding site would influence the biochemical
properties of the ERT-mt6 RT. Single-amino-acid substitutions
wereintroducedintothep66chain ofERT-mt6,andtheireffectson
the overall DNA polymerization activity, IC50 of AZTTP, Km value,
kcat value, and Ki value of ATP for the ERT-mt6 RT were analyzed.
The positions of the substitutions introduced corresponded to
positions 72, 110, 113, 116, and 219 of the 93JP-NH1 p66. We did
not conduct mutagenesis of D185 in the YMDD loops, because its
essential role in the translocation of the template primer has been
established [14]. All of the tested substitutions changed the overall
DNA polymerization activity of the RT (Figure S4B). The
substitutions at positions 72, 110, and 116 (R72A/Q, D110A/N,
and F116A/L) resulted in a loss of DNA polymerization activity,
suggesting their essential role in this activity. In contrast, those at
positions 113 and 219 (D113A/N and K219Q/A) enhanced the
incorporationofdTTP(FigureS4B),suggestingtheirregulatoryrole
in overall DNA polymerization activity.
The active D113A/N and K219Q/A RTs were further
examined for changes in the IC50 of AZTTP, and in the Km, kcat,
Ki
ATP,a n dKi9
ATP values. The D113A/N resulted in an
approximately 4- to 5-fold reduction in the IC50 of AZTTP (Figure
S4C), suggesting that D113 plays an important role in the
development of NRTI resistance. Km, kcat, Ki
ATP, and Ki9
ATP values
were estimated by using the substrate-velocity curves for the
D113A/N and K219Q/A RTs (Figure S4D). The D113A/N and
K219Q/A substitutions induced changes in the Km, kcat, Ki
ATP,a n d
Ki9
ATP values, suggesting that the D113 and K219 residues regulate
the Km of substrate, kcat,a n dKi values of ATP (Figure 5). The
D113A/N substitutions resulted in reductions in Km and kcat values,
which paralleled the reductions in Ki
ATP and Ki9
ATP values. The
K219Q/A substitutions resulted in increases in Km values, which
paralleled the increases in Ki
ATP values. The kinetics data implied
that residues 113 and 219 can regulate the affinity of the substrate
and ATP molecule but do not contribute directly to the catalysis of
DNA polymerization, suggesting that the ATP binding site would
be distinct from the catalytic site for DNA polymerization.
Discussion
How HIV-1 RT regulates the nucleotide selectivity for DNA
synthesis is a central issue for genetics and the NRTI resistance of
Figure 4. Docking simulations of ATP to the HIV-1 RT p66 subunit with NRTI resistance. ATP was docked with the optimized p66-
template-primer complex of the ERT-mt6 strain at the pre-translation stage, using the automated ligand docking program ASEDock2005 [22]
operated in the Molecular Operating Environment (see Materials and Methods). Catalytic clefts composed of fingers, palm, and thumb subdomains
are shown. ATP, red sticks; p66 main chain, grey ribbon; template-primer, grey sticks; motif A, blue ribbon. The side chains of amino acids around ATP
are indicated with cyan sticks, and the side chains of amino acids for NRTI resistance (M41L, T69I, L210W, and T215W) with orange sticks. The main
chain of an 11-amino-acid insertion at the b3-b4 loops for NRTI resistance is shown in orange.
doi:10.1371/journal.pone.0008867.g004
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physiological concentrations acted as an allosteric regulator of
HIV-1 RT to modulate nucleotide selectivity. We also showed
probable 3-D positions of the bound ATP molecule and NRTI
mutations in the catalytic cleft; these positions immediately
suggested that a nucleotide-selection mechanism—i.e., an ATP-
and RT-mutation-mediated modulation of the geometric selection
of nucleotides—played a role in the DNA polymerization and
NRTI resistance of HIV-1.
First, we demonstrated that the ATP molecule modulated the
Km and kcat values of the substrate for HIV-1 RT. We showed that
the ATP molecule reduced the Km values of dTTP with both
NRTI-sensitive and -resistant RTs (Figure 1C). These results
suggested that the ATP molecule can decrease the Km value of a
natural substrate to HIV-1 RT. We also showed that the ATP
molecule reduced the kcat values of these RTs (Figure 1C). These
results suggested that the ATP molecule can decrease the rate of
DNA polymerization and thereby increase the probability of an
excision reaction by HIV-1 RT. Lineweaver-Burk double-
reciprocal plots showed that the ATP molecule is a mixed
noncompetitive inhibitor of RT, suggesting distinct binding sites
for ATP and dNTP. Taken together, these data strongly suggest
that the ATP molecule can act as an allosteric regulator to
modulate the nucleotide selectivity of HIV-1 RT.
We next investigated the mechanisms by which the ATP
molecule modulates the nucleotide selectivity of HIV-1 RT.
Docking simulations predicted that the ATP-binding site would be
similar between NRTI-sensitive and -resistant RTs during DNA
polymerization. Consistent with the results of the kinetic study, the
predicted ATP-binding site was distinct from that of dNTP and
NRTIs [23], and single-amino-acid substitutions at positions 113
and 219 around the predicted ATP-binding site indeed induced
significant changes in the Ki value of ATP. Importantly, the ATP-
binding position suggested possible mechanisms by which ATP
could influence DNA polymerization and the excision reactions of
RT, as follows: First, interactions between the c-phosphate of the
ATP molecule and the side chain of D185 in the YMDD loops
could influence the DNA translocation of the primer template
[14]. Second, interactions between charged portions of the ATP
molecule and the side chains of D110 and D185 could modulate
the Mg
2+ position and stability for DNA polymerization [1].
Third, the c-phosphate of the ATP molecule is located near the 59
phosphate of DNA primer terminus and thus could increase the
probability of a DNA excision [11] in concert with a reduction in
the kcat value of RT.
We found no marked increases in the Ki values of AZTTP and
d4TTP at the ATP concentrations around the Ki9
ATP value
(1.160.4 mM) for ATP binding to the RT-template-primer-dTTP
Figure 5. Site-directed mutagenesis study of the HIV-1 RT p66 subunit with NRTI resistance. Single substitutions of amino acids around
the predicted ATP-binding site in Figure 3 were introduced into the p66 chain of ERT-mt6. The overall DNA polymerization activity (Figure S4B), IC50
of AZTTP (Figure S4C), and Km, kcat, Ki
ATP, and Ki9
ATP values were measured using the [a-
32P]dTTP and poly (rA)?p(dT)12-18 system, and fold increases in
the Km (A), kcat (B), Ki
ATP (C), and Ki9
ATP values (D) compared to those for the ERT-mt6 were calculated. Results for the RT mutants, D113A, D113N,
K219Q, and K219A, which retained sufficient polymerization activity for a kinetic study, are shown.
doi:10.1371/journal.pone.0008867.g005
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molecule was estimated to bind with equivalent Ki values to the
NRTI-sensitive and -resistant RTs, as others have indicated
[15,16], suggesting that NRTI-resistance mutations do not
necessarily increase ATP-binding affinity. Moreover, some
NRTI-resistant mutations, such as M41L and T69I, are located
relatively distantly from the ATP-binding site and catalytic site
(Figure 4), which makes their direct impact on DNA excision
unlikely. Thus, our study suggests that an ATP-mediated DNA
excision mechanism alone is insufficient to explain the roles of the
NRTI-resistance mutations, as was also noted previously [12].
Therefore, we speculate that NRTI-resistance mutations can
decrease the affinity of NRTIs to HIV-1 RT in concert with the
ATP molecule.
Our data imply that the ATP molecule and NRTI mutations
can modulate the nucleotide selectivity of HIV-1 RT by
influencing the geometric selection of nucleotides in the catalytic
cavity, as follows: First, the presence of bound ATP molecule in
the catalytic cavity can sterically influence the initial binding and
translocation of dNTP/NRTI into the catalytic site. Second, more
hydrophobic side chains of the NRTI-resistance mutations can
improve p66’s ability to exclude water from the catalytic cavity
and allow more intimate interactions between nucleotides, the
primer-template, and amino acids around the catalytic site for
distinguishing between correct and incorrect base pairs. In this
regard, previous crystal structure analyses have revealed that the
active site of a low-fidelity polymerase is more accessible to the
solvent than those of more accurate polymerases [30,31]. Third,
Ki
NRTIs values increased sharply with NRTI-resistant RT (ERT-
mt6 RT) at ATP concentrations around the Ki
ATP value
(2.861.3 mM) for ATP binding to the RT-template-primer
complex (Figures 2C and 2D). Fourth, the changes in the Km
value of dTTP correlated with those in the Ki value of the ATP
molecule to the RT-template-primer complex (Figures 5A and
5C). Taken together, our structural, kinetic and mutagenesis data
suggest that the NRTI-resistance mutations and the ATP molecule
can cooperatively modulate physicochemical properties of the p66
catalytic cavity to alter the fidelity of the geometric selection of
nucleotides and the probability of an excision reaction.
In conclusion, we demonstrated that the ATP molecule at
physiological concentrations acts as an allosteric regulator of HIV-1
RT to decrease the Km value of the substrate, decrease the kca valuet,
and increase the Ki value of NRTIs for RT. The effects were
independent of NRTI-resistance mutations of RT. The ATP
molecule and NRTI mutations could decrease RT’s sensitivity to
NRTI of RT in concert with the RT mutation. Our data support the
notion that the ATP molecule and NRTI mutations can modulate
nucleotide selectivity by altering the fidelity of the geometric selection
of nucleotides and the probability of an excision reaction.
Materials and Methods
Nucleotides
Poly(rA)Np(dT)12-18, dNTPs (100 mM, pH 7.5), NTPs (100 mM,
pH 7.5), and [a-
32P]dTTP were purchased from Pharmacia
Biotech Inc. (USA). ADP and AMP were from ICN (USA).
Adenosine 59-(b, c-imido) triphosphate (AMP-PNP) was from
Sigma Chemical (USA). 39-Azido 39-deoxythymidine 59-triphos-
phate (AZTTP), 39-deoxy-29, and 39-didehydrothymidine 59-
triphosphate (d4TTP) were from Moravek Biochemicals (USA).
Expression and Purification of HIV-1 RT
HIV-1 infectious molecular clones, 93JP-NH1 and ERT-mt6
[13], were used to clone and express the p51 and p66 subunits of
the HIV-1 RT. The open reading frames encoding the RT p51
and p66 subunits of the 93JP-NH1 and ERT-mt6 RTs were
amplified by PCR and cloned into the BamH1 site of pQE-9
(Qiagen, Germany). The nucleotide sequences of the PCR-
amplified fragments and the sequences around the cloning sites
were verified with an automated sequencer. Each subunit was
expressed individually in XL1-blue by induction with isopropyl-b-
D-thiogalactopyranoside, and the cells expressing p51 and p66
were mixed in binding buffer (20 mM sodium phosphate,
500 mM NaCl, 10 mM imidazole, and EDTA-free protease
inhibitor mixture (Roche, Germany), lysed with a French press,
centrifuged at 10,000 g for 20 min, and filtered (0.45-mm pore
size). The p51/p66 heterodimers were purified from the filtered
lysates by Ni
2+ affinity chromatography (HiTrap Chelating HP;
Amersham Biosciences, UK) and size exclusion chromatography
(HiLoad 16/60 Superdex 200 pg; Amersham Biosciences, UK).
All of the purification processes were carried out at 4uC. About 1.5
(ERT-mt6) and 3 mg (93JP-NH1) of the p51/p66 heterodimers
with greater than 95% purity as judged by SDS-polyacrylamide
gel electrophoresis (Figure S1) were obtained with a 1-liter culture.
The specific activities of the purified RTs were 40,000 and 10,000
units/mg of protein for 93JP-NH1 and ERT-mt6, respectively,
wherein one unit is defined as the amount of enzyme required
for incorporation of 1.0 nmol of
32P-dTTP into poly(rA)/
poly(dT)12-18 in 10 min at 37uC.
Measurement of RT Activity
The purified RTs were dissolved in the RT stock buffer (50 mM
Tris-HCl pH 7.5, 75 mM KCl, 5 mM MgCl2, 2 mM DTT,
0.05% NP40, and 50% glycerol)[32,33] and kept at 230uC until
use. RNA-dependent DNA polymerase activity was measured
using [a-
32P]dTTP and poly(rA)/poly(dT)12-18 as described
previously [33]. For the RT reaction in the presence of ATP,
RT activities were measured in 100 ml of RT reaction cocktail
consisting of 50 mM Tris-HCl pH 7.5, 75 mM KCl, 5 mM
MgCl2, 2 mM DTT, 0.05% NP40, and 50% glycerol containing
RT (1–10 nM), dTTP (0.2–18 mM), and ATP (0–4 mM). For the
RT reaction in the presence of ATP and NRTI, RT activities were
measured in 100 ml of the RT reaction cocktail containing RT (1–
10 nM), dTTP (0.2–18 mM), ATP (0–5 mM), and AZTTP or
d4TTP (0–1 mM). These experiments were performed in duplicate
and repeated two to six times.
Steady-State Kinetic Analysis
The averages of the experimental data were fit by a nonlinear
regression method using the program Igor Pro (WaveMetrics,
USA). The kinetics parameters were determined by the Michaelis-
Menten equation:
v~
Vmax
app½S 
Km
appz½S 
, ð1Þ
where [S] is the substrate concentration; Km
app is the apparent
Michaelis-Menten constant; and Vmax
app is the apparent maximal
rate attained when the enzyme active sites are saturated by
substrate.
Based on the kinetics data in Figure 1 and Figure S2, the
previously reported kinetics data [17,18], and a crystal structure
study of the ATP-RT complex [11], we assumed mixed
noncompetitive inhibition of ATP and competitive inhibition of
NRTIs (Figure 2C).
Using this model, the enzyme kinetic parameters were
calculated using Equations 2–5.
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app and Km
app are defined as
Vmax
app~kcat
app½E ð 2Þ
and
Km
app~Km
(1z
½I 
Ki
)
(1z
½I 
Ki
0 )
, ð3Þ
respectively, where Km is the Michaelis-Menten constant; [E] is the
enzyme concentration; [I] is the inhibitor concentration; Ki and Ki9
are the inhibition constants for the enzyme and the complex of the
enzyme with substrate; and kcat
app is the apparent turnover number:
kcat
app~
kcat
(1z
½I 
Ki
0 )
, ð4Þ
where kcat is the turnover number.
The kcat
app and Km
app that can be derived from the model
(Figure 2C) are
kcat
app~
kcat
(1z
½IATP 
K
0ATP
i
)
ð5Þ
and
Km
app~
Km(1z
½IATP 
KATP
i
z
½IAZT 
KAZT
i
z
½IAZT ½IATP 
K
00ATP
i KAZT
i
)
(1z
½IATP 
K
0ATP
i
)
, ð6Þ
where Ki
ATP is the dissociation constant of ATP; Ki
AZTTP is the
dissociation constant of AZTTP; [I
ATP] is the ATP concentration;
and [I
AZTTP] is the AZTTP concentration.
Structural Analysis
We constructed the 3-D models of HIV-1 RTs by homology
modeling [19] using the Molecular Operating Environment, MOE
(Chemical Computing Group, Canada) as previously described
[34]. We generated models of the 93JPNH-1 RT and ERT-mt6 RT
structures at the pre- and post-translocation stages, which
theoretically are competent for the binding of the incoming-ATP.
We used two crystal structures of the HIV-1 RTs (PDB code: 1N6Q
[14] and 1RTD [1]) as modeling templates. The sequence identities
of the 1N6Q and 1RTD with the 93JPNH-1 RT and ERT-mt6 RT
are ,90%. We optimized the 3-D structure thermodynamically by
energy minimization using MOEand an AMBER94 force field. We
further refined the physically unacceptable local structure of the
models on the basis of evaluation by the Ramachandran plot using
MOE. The optimized models were docked with ATP with the
automated ligand docking program ASEDock2005 [22] (Ryoka
Systems, Japan) operated in the Molecular Operating Environment.
The RT-template-primer-ATP complex structures were thermody-
namically and sterically optimized as described above.
Site-Directed Mutagenesis
Site-directed mutagenesis was performed with a QuikChange
Multi Site-Directed Mutagenesis Kit (Stratagene, USA), using
pQE70 (Qiagen, Germany) containing the coding sequence of the
p66 subunit of ERT-mt6 as the template. The positions of the
amino acid substitutions corresponded to the positions 72, 110, 113,
116, and 219 of 93JP-NH1. The mutations and oligonucleotides
used in the mutagenesis reaction were R72A (59-CGGCCAGCA
TTAAATGGgcGAAATTAGTAGATTTCAGAGAG-39), R72Q
(59-CGGCCAGCATTAAATGGcaGAAATTAGTAGATTTCA-
GAGAG-39), D110A (59-GAAAAAATCAGTAACAGTACTAG-
cTGTGGGAGATGCATATTTTTC-39), D110N (59-GAAAAA-
ATCAGTAACAGTACTAaATGTGGGAGATGCATATTTT-
TC-39), D113A (59-CAGTACTAGATGTGGGAGcTGCATAT-
TTTTCAGTTCCTT-39), D113N (59-CAGTACTAGATGTGG-
GAaaTGCATATTTTTCAGTTCCTT-39), F116A (59-GGAA-
CTGAAgcATATGCATCTCCCACATCTAGTACTG-39), F116L
(59-GGAACTGAcAAATATGCATCTCCCACATCTAGTACT-
G-39), K219A (59-GGGATTTTATACACCAGACgcAAAGCAT-
CAGAAGGAACCTC-39), and K230(219)Q (59-GGGATTTTA-
TACACCAGACcAAAAGCATCAGAAGGAACCTC-39), where
the introduced mutations appear in lowercase letters. In all cases,
the nucleotide sequences of the complete p66 coding region and of
cloning sites were verified with an automated sequencer. The
mutant p66 subunits were expressed in XL1-blue and used to form
the p51/p66 heterodimer using the p51 subunit of 93JP-NH1 in
binding buffer, as described above. The p51/p66 heterodimers
were purified by Ni
2+ affinity chromatography. About 104 to
221 mg of the p51/p66 heterodimers, with about 90% purity as
judged by SDS-polyacrylamide gel electrophoresis (Figure S4A),
were obtained from a 20 ml culture. The purified RTs were
dissolved in the RT stock buffer and kept at 230uC until use.
Supporting Information
Figure S1 Data on RTs of 93JP-NH1 and ERT-mt6. A.
Electrophoresis of the purified p51/p66 heterodimers of HIV-1
RTs. The purified p51/p66 heterodimers of 93JP-NH1 RT (NH1)
and ERT-mt6 RT (mt6) were electrophoresed on an SDS-4/20%
polyacrylamide gradient gel. The gel was stained with GelCode
Blue Stain Reagent (Pierce, USA). (Lanes 1 and 4) Molecular size
markers. B. The substrate-velocity curves of purified HIV-1 RTs.
RNA-dependent DNA polymerase activity at the indicated
concentrations of [a-
32P]dTTP was measured using purified
RTs of 93JP-NH1 (1 nM) and ERT-mt6 (10 nM).
Found at: doi:10.1371/journal.pone.0008867.s001 (0.29 MB TIF)
Figure S2 Lineweaver-Burk double-reciprocal plots of AZTTP-
dependent inhibition of dTTP incorporation. A. 93JP-NH1 RT.
B. ERT-mt6. The initial velocities of dTMP incorporation into
poly (rA)?p(dT)12-18 were measured using [a-
32P]dTTP and
purified RTs in the presence of AZTTP. Reciprocal values of
the initial velocities and substrate concentrations are plotted.
Found at: doi:10.1371/journal.pone.0008867.s002 (0.15 MB TIF)
Figure S3 Docking simulations of ATP with RT-template-primer
ternary complex models. A and C: 93JP-NH1 RT. B and D: ERT-
mt6 RT. The 3-D models of the p66-template-primer complexes at
the pre-translation stage (A and B) and the post-translation stage (C
and D) were constructed by a homology modeling technique and
docked with ATP using the ASEDock2005 (see Materials and
Methods). Catalytic clefts composed of fingers, palm, and thumb
subdomains are shown. ATP, red sticks; p66 main chain, grey
ribbon; template-primer, grey sticks; motif A, blue ribbon.
Found at: doi:10.1371/journal.pone.0008867.s003 (1.93 MB TIF)
Figure S4 Data on RT mutants from the ERT-mt6 RT. A.
Electrophoresis of the purified RT mutants from the ERT-mt6
RT. B. dTMP incorporations into poly (rA)?p(dT)12-18 by the
Regulation of HIV RT by ATP
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purified RTs (20 nM) was measured using a [a-
32P]dTTP and
poly (rA)?p(dT)12-18 system. C. Fold increases in the IC50 of
AZTTP by ATP addition. IC50 values of AZTTP with RT
mutants were calculated from the amounts of [a-
32P]dTTP
incorporation in the presence of various concentrations (0–
1 mM) of AZTTP and 5 mM ATP. Fold increases in IC50
compared to the values without ATP are shown. D. The substrate-
velocity curves of purified HIV-1 RTs in the presence of ATP.
RNA-dependent DNA polymerase activity of the purified mutant
RTs was measured using various concentrations of [a-
32P]dTTP
and poly (rA)?p(dT)12-18 in the presence of ATP. Representative
results with D113A RT (left) and K219A RT (right) are shown.
Found at: doi:10.1371/journal.pone.0008867.s004 (0.39 MB TIF)
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